LINC00851

Across TCGA pan-cancer cohorts, LINC00851 RNA is linked to patient survival in 14 of 34 cancer types, making it the most broadly survival-associated LINC00851 data layer.

The strongest signal is observed in liver hepatocellular carcinoma (LIHC), where higher LINC00851 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated LINC00851 expression acts as an unfavorable survival marker, although some lineages such as BLCA and LUSC show a favorable association.

LIHC, PAAD, and BLCA are the cancer types where LINC00851 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
LIHC	OS	Tertile	II,III,IV	0.199	0.628	<.001	63	view →
PAAD	DFS	Tertile	All	0.178	0.479	<.001	54	view →
BLCA	OS	Tertile	II,III,IV	0.915	0.693	.006	45	view →
LUSC	DFS	Quartile	II,III,IV	0.763	0.554	.001	45	view →
KIRC	OS	Tertile	All	0.524	0.653	.012	44	view →
TGCT	DFS	Quartile	All	0.642	0.843	.004	32	view →
UCEC	DFS	Tertile	All	0.755	0.854	.007	30	view →
LUAD	DFS	Tertile	IV	0.223	0.710	.043	18	view →
UCS	OS	Tertile	IV	0.269	0.624	.042	18	view →
SKCM	DFS	Tertile	II,III,IV	1.000	0.675	.008	15	view →
SARC	DFS	Tertile	All	0.579	0.314	.012	15	view →
BRCA	DFS	Tertile	III,IV	0.778	0.885	.020	12	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 14 lineages.

LINC00851–LIHC (OS)

Open the LIHC breakdown →